English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    O. V. Bachynska, S. I. Doan, L. V. Zakordonets, V. V, Kozlov, M.O Makarenko, O. A. Gerasymenko, O. V. Pavlenko

    CUMULATIVE ANTIBIOGRAM IN THE SELECTION OF EMPIRIC ANTIBIOTIC THERAPY


    About the author: O. V. Bachynska, S. I. Doan, L. V. Zakordonets, V. V, Kozlov, M.O Makarenko, O. A. Gerasymenko, O. V. Pavlenko
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation Local microbiological monitoring was carried out based on the results of bacteriological studies of clinical samples from 892 patients in the departments of anesthesiology, intensive care and surgical departments in a multidisciplinary hospital. 1086 microorganisms were isolated, of which 837 isolates of bacterial pathogens (77.07 %) and 249 isolates of Candida fungi were isolated. Among the detected bacterial pathogens, gram-negative bacteria probably prevailed (p<0.001) over gram-positive ones (568 (67.86 %) and 269 (32.14 %), respectively). Among gram-negative bacteria, Escherichia coli (46.83 %) (p<0.001) was isolated more often, Pseudomonas aeruginosa (20.77 %) (p<0.05) and Klebsiella pneumoniae (15.67 %) were less frequently detected. Probably (p<0.001) more often (in 258 out of 568 cases) the indicated pathogens were detected in clinical samples of washings from the skin area around the installed peripheral vascular catheter: E. coli (44.57 %), Ps. aeruginosa (21.71 %), Kl. pneumoniae (16.28 %) and other gram-negative bacteria (17.44 %). The results of the cumulative antibiogram indicate the low sensitivity of E. coli to most antimicrobial drugs, which is a very threatening situation, taking into account the fact that as empirical antibiotic therapy, a drug with a sensitivity of at least 80.0 % can be used according to the results of local microbiological monitoring according to previous year The actual results of the study indicate the need to implement a cumulative antibiogram in the work of medical institutions that provide round-the-clock inpatient care. The need for dynamic assessment of the susceptibility of pathogens causing healthcare-associated infections to antibacterial drugs is vital, especially for the sick departments of anesthesiology and intensive care and the surgical profile. The introduction of the results of the cumulative antibiogram into the standard operating procedures is a primary task in the administration of the use of antibacterial and antifungal drugs.
    Tags cumulative antibiogram,antimicrobial resistance,empiric antibiotic therapy
    Bibliography
    • Bereznyakov VI, Korzh AN, Pavlov SB, Yeroshenko GA, Shevchenko KV, Zvyagolska IM et al. Zahalna kharakterystyka khvorykh iz pozalikarnianoyu pnevmoniieyu, shcho proishly vidkryte porivnialne doslidzhennia. Svit medytsyny ta biolohiyi. 2022. 3 (81);17–21.http://dx.doi.org/10.26724/2079-8334-2022-3-81-17-21 [in Ukrainian]
    • Nakaz MOZ Ukrainy vid 19.08.2021 № 1766 “Pro zatverdzhennia Poriadku zdiisnennia dozornoho epidemiolohichnoho nahliadu za protymikrobnoyu rezystentnistiu”. Zareiestrovano v Ministerstvi yustytsiyi Ukrayiny 11 zhovtnia 2021 r. za No.  1316/36938. https://zakon.rada.gov.ua/laws/show/z1316-21#Text [in Ukrainian]
    • Nakaz MOZ Ukrainy vid 23.08.2023 №1513 “Pro zatverdzhennia Standartu medychnoyi dopomohy “Ratsionalne zastosuvannia antybakterialnykh i antyfunhalnykh preparativ z likuvalnoyu ta profilaktychnoyu metoyu” [in Ukrainian]
    • Nakaz MOZ Ukrainy vid 03.08.2021 №1614 “Pro orhanizatsiyu profilaktyky infektsiyi ta infektsiinoho kontroliu v zakladakh okhorony zdorovyia ta ustanovakh/ zakladakh nadannia sotsialnykh posluh/ sotsialnoho zakhystu naselennia” Zareiestrovano v Ministerstvi yustytsiyi Ukrayiny 11 zhovtnia 2021 r.za # 1318/36940 https://zakon.rada.gov.ua/laws/show/z1318-21#Text [in  Ukrainian]
    • Bashir N, Dablool AS, Khan MI, Almalki MG, Ahmed A, Mir MA et al. Antibiotics resistance as a major public health concern: A pharmaco-epidemiological study to evaluate prevalence and antibiotics susceptibility-resistance pattern of bacterial isolates from multiple teaching hospitals. J Infect Public Health. 2023 Dec;16 Suppl 1:61–68. doi: 10.1016/j.jiph.2023.09.019.
    • Bielec F, Wenecka M, Brauncajs M, Pastuszak-Lewandoska D. Analysis of Cumulative Antibiogram Reports in Search for Optimal Empirical Urinary Tract Infection Treatment at the Central Teaching Hospital of the Medical University of Lodz, Poland: Results of a 3-Year Surveillance. J Clin Med. 2023 Sep 28;12(19):6270. doi: 10.3390/jcm12196270.
    • Darboe S, Mirasol R, Adejuyigbe B, Muhammad AK, Nadjm B, De St Maurice A. et al Using an Antibiogram Profile to Improve Infection Control and Rational Antimicrobial Therapy in an Urban Hospital in The Gambia, Strategies and Lessons for Low- and Middle-Income Countries. Antibiotics (Basel). 2023 Apr 21;12(4):790. doi: 10.3390/antibiotics12040790.
    • Essamedin MN, Eman SE, Shahenda GB, AL ZM, Aya M, El S et al. Analysis of cumulative antibiogram reports in intensive care units at an Egyptian University Hospital Journal of Infection and Public Health. 2023 (16);1220–1229. https://doi.org/10.1016/j.jiph.2023.05.032
    • Krishnamoorthy SG, Raj V, Viswanathan B, Dhanasekaran GP, Palaniappan D, Borra SS. Enhancing the empiric antibiotic selection by introducing an antibiogram toolkit in a tertiary care hospital in Southern India – A prospective study. J Clin Pharm Ther. 2022 Apr;47(4):507–516. doi: 10.1111/jcpt.13571.
    • Sakai T, Morimoto Y. The History of Infectious Diseases and Medicine. Pathogens. 2022 Oct 4;11(10):1147. doi:  10.3390/pathogens11101147.
    • Simner PJ, Hindler JA, Bhowmic.k T, Das S, Johnson JK, Lubers BV et al. What's New in Antibiograms? Updating CLSI M39 Guidance with Current Trends. J Clin Microbiol. 2022 Oct 19;60(10):e0221021. doi: 10.1128/jcm.02210-21.
    • Truong WR, Hidayat L, Bolaris MA, Nguyen L, Yamaki J. The antibiogram: key considerations for its development and utilization. JAC Antimicrob Resist. 2021 May 25;3(2):dlab060. doi: 10.1093/jacamr/dlab060.
    • WHO Regional Office for Europe and European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe, 2020 data. Executive Summary. Copenhagen: WHO Regional Office for Europe; 2021: 1–5.
    Publication of the article «World of Medicine and Biology» №1(87), 2024 year, 025-031 pages, index UDK 615.33.015.8:616-78]-092
    DOI 10.26724/2079-8334-2024-1-87-25-31